These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 27720585)
21. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943 [TBL] [Abstract][Full Text] [Related]
22. Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity. Hepel JT; Yashar C; Leonard KL; Einck JP; Sha S; DiPetrillo T; Wiggins D; Graves TA; Edmonson D; ; Wazer DE Brachytherapy; 2018; 17(5):825-830. PubMed ID: 29936130 [TBL] [Abstract][Full Text] [Related]
23. Mammographically guided noninvasive breast brachytherapy: Preoperative partial breast radiotherapy markedly improves targeting accuracy and decreases irradiated volume. Leonard KL; Wazer DE; Listo M; Hepel JT Brachytherapy; 2021; 20(2):339-344. PubMed ID: 33293214 [TBL] [Abstract][Full Text] [Related]
24. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. Vicini FA; Keisch M; Shah C; Goyal S; Khan AJ; Beitsch PD; Lyden M; Haffty BG Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):512-8. PubMed ID: 22079730 [TBL] [Abstract][Full Text] [Related]
25. Accelerated partial breast irradiation for pure ductal carcinoma in situ. Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374 [TBL] [Abstract][Full Text] [Related]
26. Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis. Shah C; Khwaja S; Badiyan S; Wilkinson JB; Vicini FA; Beitsch P; Keisch M; Arthur D; Lyden M Brachytherapy; 2013; 12(4):278-84. PubMed ID: 23664895 [TBL] [Abstract][Full Text] [Related]
27. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V; Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198 [TBL] [Abstract][Full Text] [Related]
28. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial. Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672 [TBL] [Abstract][Full Text] [Related]
29. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Vicini FA; Beitsch PD; Quiet CA; Keleher A; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer H; Whitacre EB; Whitworth PW; Fine RE; Haffty BG; Arrambide LS Cancer; 2005 Sep; 104(6):1138-48. PubMed ID: 16088962 [TBL] [Abstract][Full Text] [Related]
30. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience. Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920 [TBL] [Abstract][Full Text] [Related]
31. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer. Bhandari T; Babaran W; Forouzannia A; Williams V; Harness J; Carpenter M; Gobran M; Khanijou R; Wagman B; Ash R; Wagman LD Brachytherapy; 2017; 16(6):1232-1238.e2. PubMed ID: 29032999 [TBL] [Abstract][Full Text] [Related]
32. Comparison of subjective, objective and patient-reported cosmetic outcomes between accelerated partial breast irradiation and whole breast radiotherapy: a prospective propensity score-matched pair analysis. Wadasadawala T; Sinha S; Parmar V; Verma S; Gaikar M; Kannan S; Mondal M; Pathak R; Jain U; Sarin R Breast Cancer; 2020 Mar; 27(2):206-212. PubMed ID: 31512161 [TBL] [Abstract][Full Text] [Related]
33. Impact of the radiation boost on outcomes after breast-conserving surgery and radiation. Murphy C; Anderson PR; Li T; Bleicher RJ; Sigurdson ER; Goldstein LJ; Swaby R; Denlinger C; Dushkin H; Nicolaou N; Freedman GM Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):69-76. PubMed ID: 20732766 [TBL] [Abstract][Full Text] [Related]
34. Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer. Wong WW; Pockaj BA; Vora SA; Halyard MY; Gray RJ; Schild SE Breast J; 2014; 20(2):125-30. PubMed ID: 24372873 [TBL] [Abstract][Full Text] [Related]
35. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients. Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241 [TBL] [Abstract][Full Text] [Related]
36. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon. Rajan SS; Sharma SC; Kumar N; Kumar R; Singh G; Singh R; Tomar P J Cancer Res Ther; 2014; 10(4):889-95. PubMed ID: 25579524 [TBL] [Abstract][Full Text] [Related]
37. Quality of life and cosmesis after breast cancer: whole breast radiotherapy vs partial breast high-dose-rate brachytherapy. Perrucci E; Lancellotta V; Bini V; Falcinelli L; Farneti A; Margaritelli M; Capezzali G; Palumbo I; Aristei C Tumori; 2015; 101(2):161-7. PubMed ID: 25768319 [TBL] [Abstract][Full Text] [Related]
38. High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer. Guinot JL; Baixauli-Perez C; Soler P; Tortajada MI; Moreno A; Santos MA; Mut A; Gozalbo F; Arribas L Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):165-71. PubMed ID: 25446608 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625 [TBL] [Abstract][Full Text] [Related]
40. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer. Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]